Company Information
Product Portfolio
Investors
Partnerships
 

COMPANY INFORMATION

History

The company was founded in 2005 and has laboratories and offices in Research Triangle Park, North Carolina.

Strategy

The Company strategy is to use its broad product and technology platform to develop a portfolio of botanical prescription drugs, while simultaneously generating revenues and licensing fees from other value-added sources (see Partnerships). PhytoPharmacon has identified a number of drug candidates in oncology, cardiovascular disease, and the anti-inflammatory field including asthma. By selecting drug candidates whose efficacy and safety have already been established over hundreds of years in China, India, USA and Europe, PhytoPharmacon expects to be able to reduce the time taken to bring these proprietary botanical drugs to market.

Management

The Company management has extensive experience in all aspects of the development and commercialization of pharmaceutical and biological products.

Ven Subbiah, Ph. D. Founder/ President:

Dr. Subbiah is Founder/President, and CSO of PhytoMyco Research Corporation, Greenville, NC; Founder/Chairman, of PhytoMyco Res. Pvt. Ltd. Mysore, India. He worked as Principal Investigator at RJR-Nabisco and was Senior Research Scientist at OSI Pharmaceuticals, Uniondale, NY, USA. Dr. Subbiah has published 80 papers, and has10 issued patents and 20 patents pending.


Inderjit K. Dev, Ph. D. Co-founder and V.P. of R&D.

Dr. Dev received his degree from UNC, Chapel Hill and has more than 35 years of experience in pharmaceutical drug discovery working for GlaxoSmithKline in the areas of anticancer, antimicrobial and antiviral therapeutics. He has published 65 scientific papers and has 13 patents issued and pending.

 


Gabriel Cipau, MBA, Ph.D., MBA, CEO.

Dr. Cipau, a partner with Key Healthcare Partners, is a seasoned pharmaceutical executive and chemical engineer. He was President and CEO of Nippon Wellcome KK, Copley Pharmaceuticals, Catalytica Pharmaceuticals and Biolex. He is a member of the Board of Directors for ENS Inc. and Bob Barker Co.

 


Advisors

Amy DelaCourt Cipau, MBA, Marketing and Business Development Advisor.

Amy, a partner with Key Healthcare Partners, was past Vice President Pharmaceutical Marketing and Sales for Catalytica Pharmaceuticals Inc. and Director of Marketing and Commercial Strategy for Medco Research Inc. and Copley Pharmaceuticals. She was Senior Product Manager at Burroughs Wellcome for several major brands.

  • Dr. Irving G. Joshua, Professor and Chair, University of Louisville, KY, Pre-clinical advisor.
  • Fred Hutchison, Hutchison Law Group PLLC, Corporate counsel.
  • Jim Passe, Passé Intellectual Property, LLC, IP counsel.